AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Enristas 3MF Tablet SR

Prescription Icon
Prescription Required

Marketer

Anthem Biopharma

Salt Composition

Glimepiride (3mg) + Metformin (1000mg)

Overview Enristas 3MF Tablet SR

Diabex Duo SR tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabex Duo SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continue taking this medication even if feeling well or if blood sugar is controlled; abrupt cessation without medical consultation can elevate blood sugar, increasing the risk of complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication is only one component of a comprehensive diabetes management plan, which also includes a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. The most frequent adverse effect of Diabex Duo SR is hypoglycemia (low blood sugar). Learn to recognize hypoglycemia symptoms—sweating, lightheadedness, headache, tremors—and how to address them. Maintain regular meals and carry a rapid-acting glucose source, such as sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver disease. Disclose any history of heart disease to your physician before initiating treatment; it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring is crucial, and your doctor may order blood tests to monitor blood cell counts and liver function.

Primary Ingredients of Enristas 3MF Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Enristas 3MF Tablet SR

Managing type 2 diabetes

Major Benefits of Enristas 3MF Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Enristas 3MF Tablet SR with a meal.

Common Side effects of Enristas 3MF Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Enristas 3MF Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Enristas 3MF Tablet SR. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication with a meal.

How Enristas 3MF Tablet SR works:

Enristas 3MF SR tablets combine glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates pancreatic insulin release, reducing blood glucose levels. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Enristas 3MF Tablet SR and alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Enristas 3MF Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Consult your doctor for advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Enristas 3MF tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Enristas 3MF Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Enristas 3MF Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. Low initial doses are typically prescribed for those with mild to moderate liver disease; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Enristas 3MF Tablet SR :

Should you forget to take your Enristas 3MF Tablet SR, administer it promptly. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Enristas 3MF Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Enristas 3MF Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Enristas 3MF Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Enristas 3MF Tablet SR and seek immediate medical attention.
Enristas 3MF Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for treating type 1 diabetes.
Enristas 3MF Tablet SR may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Enristas 3MF Tablet SR use can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 intake at least annually is recommended by some researchers.
Enristas 3MF Tablet SR can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Enristas 3MF Tablet SR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Enristas 3MF Tablet SR
108
MRP 125
13% off